Concepedia

Eva Camarillo‐Retamosa

EC

Statistics

Publications

4

Citations

383

H-Index

4

Active since

2009

Affiliations

Orbsen Therapeutics (Ireland)(Current)

Eva Camarillo‐Retamosa is an author at Orbsen Therapeutics (Ireland) specializing in immunosuppressive function, cell biology, and life sciences.

ORCID

Publications per year

2009–2023

4

Publications

4

Requirement of IFN-γ–Mediated Indoleamine 2,3-Dioxygenase Expression in the Modulation of Lymphocyte Proliferation by Human Adipose–Derived Stem Cells

Olga DelaRosa, Eleuterio Lombardo, Aitor Beraza et al. · Tissue Engineering Part A · 2009 · 268 citations

, , +16

Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion

Paul Loftus, Luke Watson, Laura Deedigan et al. · International Journal of Cancer · 2020 · 68 citations · Full text

, , +17

Differential coexpression of FoxP1, FoxP2, and FoxP4 in the Zebra Finch (<i>Taeniopygia guttata</i>) song system

Ezequiel Mendoza, Kirill Tokarev, Daniel N. Düring et al. · The Journal of Comparative Neurology · 2014 · 37 citations

, , +15

Protein atlas of fibroblast specific protein 1 (FSP1)/S100A4.

Bettina Marturet Fendt, Astrid Hirschmann, Malgorzata Bruns et al. · PubMed · 2023 · 10 citations

, , +17

1–4 of 4